logo
Plus   Neg
Share
Email

Kohl's Slashes FY19 Adj. EPS Guidance - Quick Facts

While reporting financial results for the third quarter on Tuesday, retailer Kohl's Corp. (KSS) slashed its adjusted earnings guidance for the full-year 2019. For the third quarter, the company reported that comparable sales increased 0.4 percent.

For fiscal 2019, the company slashed its adjusted earnings guidance to a range of $4.75 to $4.95 from the prior guidance range of $5.15 to $5.45 per share.

The current guidance excludes $0.22 per share related to the extinguishment of debt and impairments, store closing and other costs recognized in the first nine months of 2019.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $5.19 per share for the year. Analysts' estimates typically exclude special items.

Last week, Kohl's Board of Directors declared a quarterly cash dividend on the Company's common stock of $0.67 per share, payable on December 24, 2019 to shareholders of record at the close of business on December 11, 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from... CVS Health Corp. launched 13 new HealthHUB locations in CVS Pharmacy stores across Philadelphia and South New Jersey. The healthcare company said it developed the HealthHUB store format to help people manage chronic conditions more conveniently and affordably. The store also features health and wellness products, clinical services and expertise.
Follow RTT
>